fulvestrant has been researched along with agar in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Arment, R; Demers, L; Fischer, S; Franks, M; Griffith, J; Leiby, B; Manni, A; Mauger, D; Verderame, M; Washington, S | 1 |
| Garber, J; Heulings, R; Lareef, MH; Russo, IH; Russo, J; Russo, PA | 1 |
2 other study(ies) available for fulvestrant and agar
| Article | Year |
|---|---|
S-adenosylmethionine decarboxylase overexpression reduces invasiveness and tumorigenicity in nude mice of MCF-7 breast cancer cells.
Topics: Adenosylmethionine Decarboxylase; Agar; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Division; Collagen; DNA-Binding Proteins; Drug Combinations; Epidermal Growth Factor; Estradiol; Female; Fulvestrant; Humans; Laminin; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Proteoglycans; Sensitivity and Specificity; STAT3 Transcription Factor; Tamoxifen; Trans-Activators; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2001 |
The estrogen antagonist ICI-182-780 does not inhibit the transformation phenotypes induced by 17-beta-estradiol and 4-OH estradiol in human breast epithelial cells.
Topics: Agar; Breast; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proliferation; Collagen; Dose-Response Relationship, Drug; Drug Combinations; Epithelial Cells; Estradiol; Estrogen Receptor alpha; Estrogens; Estrogens, Catechol; Female; Flow Cytometry; Fulvestrant; G1 Phase; Humans; Laminin; Neoplasm Invasiveness; Phenotype; Proteoglycans; Resting Phase, Cell Cycle | 2005 |